NL-OMON25186已完成不适用
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomide.
Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON) P/a HOVON Data Center; Erasmus MC; Postbus 2040; 3000 CA Rotterdam Tel: +31 10 704 1560; Fax +31 10 704 1028 e-mail: hdc@erasmusmc.nl0 个研究点目标入组 668 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 668
研究概览
简要总结
/A
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1. Previously untreated patients with a confirmed diagnosis of symptomatic multiple myeloma according to IMWG criteria ;
- •2. Age > 65 years or patients <= 65 not eligible for high dose chemotherapy and peripheral stem cell transplantation;
排除标准
- •1. Non-secretory MM;
- •2. Known hypersensitivity to thalidomide;
研究者
相似试验
已完成
不适用
Randomized phase III study in elderly patients with a multiple myeloma on the value of Thalidomide added to Melphalan plus Prednisone.Multiple myelomaNL-OMON25578Stichting Hemato-Oncologie voor Volwassenen Nederland (HOVON)P/a HOVON Data CenterErasmus MC - Daniel den HoedPostbus 52013008 AE RotterdamTel: 010 4391568Fax: 010 4391028e-mail: hdc@erasmusmc.nl420
进行中（未招募）
1 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by Thalidomide maintenance versus MP-Lenalidomide (MP-Len) follwed by maintenance with Lenalidomide.Multiple MyelomaEUCTR2007-004007-34-SEHOVON Foundation668
已完成
3 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomideKahlers disease10035227Multiple MyelomaNL-OMON50624HOVO500
进行中（未招募）
1 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomide - HOVON 87 MMMedDRA version: 14.1Level: PTClassification code 10028228Term: Multiple myelomaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Multiple MyelomaEUCTR2007-004007-34-DKHOVON Foundation668
进行中（未招募）
1 期
Randomized phase III trial in elderly patients with previously untreated symptomatic Multiple Myeloma comparing MP-Thalidomide (MP-Thal) followed by thalidomide maintenance versus MP-Lenalidomide (MP-Len) followed by maintenance with lenalidomideMedDRA version: 21.0 Level: LLT Classification code 10028228 Term: Multiple myeloma System Organ Class: 100000004864Multiple MyelomaEUCTR2007-004007-34-NLHOVON Foundation668